{"id":12682,"date":"2008-12-23T10:30:00","date_gmt":"2008-12-23T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/aboutpharma-rassegna-stampa-dal-191208-al-221208\/"},"modified":"2008-12-23T10:30:00","modified_gmt":"2008-12-23T09:30:00","slug":"aboutpharma-rassegna-stampa-dal-191208-al-221208","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/aboutpharma-rassegna-stampa-dal-191208-al-221208\/","title":{"rendered":"ABOUTPHARMA, Press Review from 12\/19\/08 to 12\/22\/08"},"content":{"rendered":"<p><strong><strong><font face=\"Arial\" color=\"#ff0000\" size=\"4\"><span style=\"font-size: 14pt; color: red; font-family: Arial\">Press Review from<\/span><\/font><\/strong><\/strong><font face=\"Arial\" color=\"#ff0000\" size=\"4\"><span style=\"font-size: 14pt; color: red; font-family: Arial\"> <strong><strong><font face=\"Arial\"><span style=\"font-family: Arial\">19\/12\/08<\/span><\/font><\/strong><\/strong><\/span><\/font><strong><strong><font face=\"Times New Roman\" color=\"#ff0000\"><span style=\"color: red\">&nbsp;<\/span><\/font><\/strong><\/strong><strong><strong><font face=\"Arial\" color=\"#ff0000\" size=\"4\"><span style=\"font-size: 14pt; color: red; font-family: Arial\">to the<\/span><\/font><font color=\"#ff0000\"><span style=\"color: red\">&nbsp;<\/span><\/font><\/strong><\/strong><strong><strong><font face=\"Arial\" color=\"#ff0000\" size=\"4\"><span style=\"font-size: 14pt; color: red; font-family: Arial\">22\/12\/08<\/span><\/font><\/strong><\/strong><font face=\"Arial\" color=\"#ff0000\" size=\"4\"><span style=\"font-size: 14pt; color: red; font-family: Arial\">&nbsp;<\/span><\/font><\/p>\n<p><strong><font face=\"Arial\" color=\"#000080\" size=\"2\"><span style=\"font-weight: bold; font-size: 10pt; color: navy; font-family: Arial\">&nbsp;<\/span><\/font><\/strong><\/p>\n<p><strong><font face=\"Arial\" color=\"#0000ff\" size=\"2\"><span style=\"font-weight: bold; font-size: 10pt; color: blue; font-family: Arial\">EU: Teva&#039;s purchase of Barr authorized<\/span><\/font><\/strong><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">(Les Echos online \u2013 December 22, 2008)<\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">Brussels has authorized the Israeli generics maker Teva to acquire the American Barr. Teva announced the $7.5 billion deal in July.<\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\"><a target=\"_blank\" href=\"http:\/\/www.aboutpharma.it\/notizia.asp?id=18550\" rel=\"noopener\">http:\/\/www.aboutpharma.it\/<wbr><\/wbr>news.asp?id=18550<\/a><\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">&nbsp;<\/span><\/font><\/p>\n<p><strong><font face=\"Arial\" color=\"#0000ff\" size=\"2\"><span style=\"font-weight: bold; font-size: 10pt; color: blue; font-family: Arial\">The NHS turns 30<\/span><\/font><\/strong><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">(Il Sole 24 Ore: page 5 \u2013 22 December 2008)<\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">On December 21, the National Health System celebrated its 30th birthday. Since 2000 WHO has indicated it as the second best health system in the world but to date, it should be noted, it has accumulated a deficit of around 57 billion euros. Open challenges to ensure its universality in the future: measuring efficiency, professionals, hospital quality, patient satisfaction.<\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\"><a target=\"_blank\" href=\"http:\/\/www.aboutpharma.it\/notizia.asp?id=18547\" rel=\"noopener\">http:\/\/www.aboutpharma.it\/<wbr><\/wbr>news.asp?id=18547<\/a><\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">&nbsp;<\/span><\/font><\/p>\n<p><strong><font face=\"Arial\" color=\"#0000ff\" size=\"2\"><span style=\"font-weight: bold; font-size: 10pt; color: blue; font-family: Arial\">Bresciani curries Landi on the Papillomavirus vaccine<\/span><\/font><\/strong><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">(Libero Milano: page 43 \u2013 20 December 2008)<\/span><\/font><\/p>\n<p><font face=\"Arial\" size=\"2\"><span style=\"font-size: 10pt; font-family: Arial\">According to the Health Councilor of the Lombardy Region, Luciano Bresciani, the decision of the Health Councilor of the Municipality of Milan, Giampaolo Landi di Chiav<\/p>","protected":false},"excerpt":{"rendered":"<p>Rassegna Stampa dal 19\/12\/08&nbsp;al&nbsp;22\/12\/08&nbsp; &nbsp; Ue: autorizzato l&#8217;acquisto di Barr da parte di Teva (Les Echos online &#8211; 22 dicembre 2008) Bruxelles ha autorizzato il produttore di generici israeliano Teva ad acquisire l&#8217;americana Barr. Teva aveva annunciato l&#8217;operazione a luglio, per un valore di 7,5 mld di dollari. http:\/\/www.aboutpharma.it\/notizia.asp?id=18550 &nbsp; Il Ssn compie 30 anni &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12682"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12682\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}